top of page

Create Your First Project

Start adding your projects to your portfolio. Click on "Manage Projects" to get started

Combination Potential

Because metabolic adaptation contributes to therapeutic resistance, MTX-101 is designed to integrate with:
• Standard-of-care chemotherapies
• Targeted therapies
• Immuno-oncology agents

By weakening tumor metabolic resilience, MTX-101 may enhance combination efficacy.

bottom of page